ArticleEJHaem2021

Pembrolizumab for the treatment of progressive multifocal leukoencephalopathy following anti-CD19 CAR-T therapy: a case report.

Strachan Mackenzie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.